GlaxoSmithKline Pakistan Limited announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was PKR 10,812.709 million compared to PKR 8,171.440 million a year ago. Operating income was PKR 1,889.303 million compared to PKR 1,246.469 million a year ago. Net income was PKR 1,126.141 million compared to PKR 923.761 million a year ago. Basic earnings per share from continuing operations was PKR 3.54 compared to PKR 2.9 a year ago. For the nine months, sales was PKR 26,585.018 million compared to PKR 25,824.915 million a year ago. Operating income was PKR 3,818.241 million compared to PKR 3,136.560 million a year ago. Net income was PKR 2,369.489 million compared to PKR 1,798.349 million a year ago. Basic earnings per share from continuing operations was PKR 7.44 compared to PKR 5.65 a year ago.